HRTX — HERON THERAPEUTICS INC

Ownership history in D.A. DAVIDSON & CO.  ·  25 quarters on record

This page tracks every 13F SEC filing in which D.A. DAVIDSON & CO. reported a position in HERON THERAPEUTICS INC (HRTX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.03% (2021 Q2)
Avg. % of fund
0.01%
First filed
2015 Q2
Last filed
2025 Q3
Quarters held
25
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 13,500 -18,000 -57.1% 0.00% $17K $1.26
2025 Q2 UNCHANGED 31,500 — 0% 0.00% $65K $2.07
2025 Q1 REDUCED 31,500 -5,500 -14.9% 0.00% $69K $2.20
2024 Q4 REDUCED 37,000 -176,630 -82.7% 0.00% $57K $1.53
21 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    HRTX price (monthly, adj. close)

Other funds also holding HRTX

As of 2025 Q4 — sorted by position size

Velan Capital Investment Management LP 3Y 6.6% Tejara Capital Ltd 3Y 1.57% JW Asset Management, LLC 3Y 7Y 1.55% Congress Park Capital LLC 3Y 7Y 1.19% Stonepine Capital Management, LLC 3Y 7Y 1.17% CM Management, LLC 3Y 0.82% Clearline Capital LP 3Y 7Y 0.78% Orchard Capital Management, LLC 3Y 0.77% Richmond Brothers, Inc. 3Y 0.47% Rubric Capital Management LP 3Y 7Y 0.47%
← Back to D.A. DAVIDSON & CO. Holdings